News

Feliza Mirasol is the science editor for 

Articles

Rentschler Biopharma now offers a new lentiviral vector manufacturing toolbox at its site in Stevenage, UK.

Rentschler Biopharma Launches New LV Vector Manufacturing Toolbox

Chris Spivey is the editorial director of 

Videos

Christian Cobaugh, CEO and founder of Vernal Biosciences, considers the outsourcing landscape for mRNA production.

A Look at the Outsourcing Landscape for mRNA (BIO 2024)

Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, 

. He previously spent nearly a decade as a news anchor, reporter, and producer at New Jersey 101.5 FM.

The International Coalition of Medicines Regulatory Authorities’ new Collaborative Hybrid Inspection Pilot program allows a CDMO to gain approval from multiple countries simultaneously, as opposed to separately phased inspections from different corners of the globe.

International Inspection Successfully Completed at PCI Pharma Services New Hampshire Campus

Under the license agreement, Andelyin Biosciences will expand its AAV Curator Platform by including MyoAAV plasmids developed by Broad Institute of MIT and Harvard.

Andelyn Biosciences Inks License Agreement with Broad Institute of MIT to Expand AAV Platform Offering

With a $15 million fund-raising goal, US Specialty Formulations plans to invest in expanding its biopharma facility in Allentown, Pa.

US Specialty Formulations Conducts $15 Million Expansion on Biopharma Operations

BioIVT has launched new cleanroom manufacturing space using Germfree’s technology that boosts its cell and gene therapies development capabilities.

BioIVT and Germfree Launch Cleanroom Manufacturing Space at Virginia Site in US

Freudenberg Medical now offers custom single-use assemblies to expand its offerings in silicone extrusion and molding for biopharma applications.

Freudenberg Adds Custom Single-Use Assemblies to Biopharma Product Portfolio

The HemoTemp II Blood Bag Temperature Indicator, which is an FDA-approved medical device, and the HemoTemp II Activator both were given the “Standards-Compliant” seal.

AABB Grants Standards Accreditation to Two SpotSee Products

Scorpius Holdings expects to launch its first CGMP campaign for mammalian-based biomanufacturing in the 2024 third quarter.

Scorpius Holdings to Launch Mammalian CGMP Manufacturing Campaign at Texas Site

Under the expanded agreement, Univercells and University of Pennsylvania will evaluate certain bioreactors for scalable gene therapy production.

Supplier News